Hospital La Paz Institute for Health Research Institute IdiPAZ

Madrid, Spain

Hospital La Paz Institute for Health Research Institute IdiPAZ

Madrid, Spain
SEARCH FILTERS
Time filter
Source Type

Prior N.,Hospital Universitario Severo Ochoa | Remor E.,Autonomous University of Madrid | Perez-Fernandez E.,Hospital Universitario Fundacion Alcorcon | Caminoa M.,Hospital La Paz Institute for Health Research IdiPaz | And 19 more authors.
Journal of Allergy and Clinical Immunology: In Practice | Year: 2016

Background: Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) may affect health-related quality of life (HRQoL). A specific HRQoL questionnaire for adult patients with C1-INH-HAE, the HAE-QoL, has recently been developed in Spain. Objective: The objective of this study was to perform a cross-cultural validation and psychometric study of the HAE-QoL in an international setting. Methods: Cross-cultural adaptation of the Spanish HAE-QoL draft version and an international rating phase with experts were performed. The resultant version of the HAE-QoL, a clinical questionnaire, and Short Form 36-item Health Survey Version 2.0 (SF-36v2) were pilot tested internationally. Item reduction was based on both descriptive and exploratory factor analysis. Psychometric properties were assessed. Results: Cross-cultural adaptation of the HAE-QoL was performed in 18 countries. The draft version of the HAE-QoL was pilot tested in 332 patients, and accurate data were obtained from 290 patients from 11 countries. The reduction process resulted in a new version with 25 items and 7 dimensions (treatment difficulties, physical functioning and health, disease-related stigma, emotional role and social functioning, concern about offspring, perceived control over illness, and mental health). Strong psychometric properties were observed (Cronbach's α 0.92; test-retest reliability 0.87). Convergent validity showed mild to moderate correlations with SF-36v2 physical and mental component summaries (0.45 and 0.64, respectively) and with SF-36v2 dimensions (P < .004). HAE-QoL scores discriminated significantly among severity groups (median: asymptomatic 133.5 vs severe 84.0; P < .001); between patients with and without long-term prophylaxis (median: 101 vs 90; P = .001); and between patients with and without psychiatric and/or psychological care (median: 74 vs 103; P ≤ .001). Conclusions: The HAE-QoL, currently available in 18 languages, showed good reliability and validity evidence. © 2016 American Academy of Allergy, Asthma & Immunology.

Loading Hospital La Paz Institute for Health Research Institute IdiPAZ collaborators
Loading Hospital La Paz Institute for Health Research Institute IdiPAZ collaborators